Welcome to the TCSL website
Projects in the Translational Correlative Studies Laboratory (TCSL) focus on the development and application of cutting-edge biomarker and correlative research studies in the context of both clinical and translational studies to support clinical trials of novel immune-based therapies to target cancer and infectious
The TCSL is located in the Center for Advanced Cellular Therapeutics on the 9th floor of the Perelman Center for Advanced Medicine South Tower.
Our manuscript in the February 2020 issue of Science describes a clinical trial in which three patients received CRISPR edited and TCR-transduced cells. Six current members of TCSL were among the authors.
Scientific publications describing TCSL research and clinical trials supported by the TCSL.
The staff members of the TCSL; their roles in the laboratory, experience and expertise.
Developing and Evaluating Immune based therapies for cancer and infectious disease
- Adoptive T cell Therapy
- Chimeric Antigen Receptor (CAR) engineered T cells to target cancer
- CTL019 (CART19) to target CD19-positive malignancies
- T cell receptor (TCR) engineered cells to target cancer
- Other gene-engineered T cell strategies to modify T cell function
Some of the people we work with
© Trustees of the University of Pennsylvania. All rights reserved. | Design: HTML5 Up!